Myeloma Today June 2003 Volume 5 Issue 6

Dear Reader

FDA Approves VELCADE® for the Treatment of Relapsed and Refractory Multiple Myeloma

Profile Interview: Julian Adams, Ph.D.

Life Lessons from a Politician

Myeloma Update: Overview of the 9th International Workshop on Multiple Myeloma International Prognostic Index, and Bank On a Cure

Letters

Q&A: Get Your Questions Answered

News & Notes

2003 IMF Anniversary Gala 

Click here to download Myeloma Today

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.